Post-Verdict Pharmacy Lien Protection: Appeals & Set-Offs

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 29, 2026 | 8 min read

Winning a verdict does not guarantee pharmacy lien recovery. Post-verdict motions, appeals, remittitur, and set-offs can reduce or eliminate the pharmacy lien component of a damages award. PI attorneys must understand how to protect pharmacy lien recovery through the post-trial process.

Post-Verdict Pharmacy Lien Protection: Appeals & Set-Offs

A favorable jury verdict that includes pharmacy costs as part of the damages award does not guarantee that the pharmacy lien will be satisfied. Post-verdict motions for remittitur, appeals challenging the damages amount, comparative fault set-offs, and collateral source reductions can all reduce the pharmacy component of the verdict below the lien balance. PI attorneys must plan for post-verdict contingencies and take specific steps to protect pharmacy lien recovery through the appellate process.

• Post-verdict motions (JNOV, remittitur, new trial) can reduce or eliminate the pharmacy damages component
• Appeals challenging damages sufficiency may target pharmacy costs as the most vulnerable element
• Comparative fault set-offs reduce the total verdict proportionally, including the pharmacy allocation
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages
• Protecting pharmacy lien recovery post-verdict requires proactive documentation of the clinical basis for pharmacy costs throughout the trial

Post-Verdict Threats to Pharmacy Lien Recovery

Remittitur. The defense moves for remittitur, arguing that the damages award — including pharmacy costs — is excessive. The court may reduce the verdict, and pharmacy costs are often the first target because they are the most easily quantified and challenged element of the damages award.

Motion for judgment notwithstanding the verdict (JNOV). The defense argues that no reasonable jury could have found pharmacy costs reasonable or necessary based on the evidence presented. If the motion succeeds, the pharmacy damages component may be eliminated entirely.

Appeal on damages sufficiency. The defense appeals the verdict, arguing that the pharmacy costs portion of the damages was not supported by sufficient evidence. Appellate courts review damages awards for abuse of discretion, and pharmacy costs without strong clinical documentation are vulnerable.

Comparative fault reduction. In comparative fault jurisdictions, the jury's fault allocation reduces the total verdict proportionally. A 30% comparative fault finding reduces every component of the damages award — including pharmacy costs — by 30%.

Collateral source set-offs. Some jurisdictions allow the defense to reduce damages by amounts the plaintiff received from collateral sources (health insurance, Medicare, etc.). If the plaintiff had insurance coverage available for some medications, the defense may argue for a set-off.

[!KEY] Pharmacy costs are often the first target of post-verdict reduction motions because they are easily quantified and the defense can argue specific line items are unreasonable. Strong clinical documentation — particularly the MERIT report — is the best defense against these motions.

Building the Trial Record for Post-Verdict Protection

Post-verdict protection begins during trial, not after the verdict. The trial record must contain sufficient evidence to withstand post-verdict challenges:

MERIT report in evidence. Ensure the MERIT report is admitted into evidence during the damages phase. This pharmacist-signed document provides the clinical foundation that appellate courts review when evaluating whether pharmacy damages were supported by sufficient evidence.

Pharmacist or expert testimony. Live testimony explaining the clinical rationale for each medication on the lien creates a trial record that is difficult to challenge on appeal. The witness should explain medical necessity, the connection between each medication and accident-related injuries, and the standard of care for pharmaceutical treatment of the plaintiff's injury profile.

Physician testimony correlation. Treating physicians should testify that they prescribed each medication based on clinical findings related to the accident. This testimony, combined with the MERIT report, creates a dual-expert foundation that is highly resistant to post-verdict attack.

According to Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist, "The MERIT report is designed to serve as both a trial exhibit and an appellate record. Its structured format — medication by medication, diagnosis by diagnosis — gives the appellate court a clear evidentiary basis for upholding the pharmacy damages award."

Defending Against Remittitur

When the defense moves for remittitur targeting pharmacy costs:

Cite the MERIT report as clinical evidence. The motion for remittitur must overcome the deference given to jury findings. Point the court to the MERIT report and pharmacist testimony as the evidentiary basis for the jury's pharmacy damages finding.

Distinguish pharmacy costs from disputed damages. Some damages components (pain and suffering, future earnings) are inherently subjective. Pharmacy costs are documented, quantified, and clinically justified. Argue that pharmacy costs are among the most well-supported elements of the damages award and should not be the target of reduction.

Present the standard of care argument. The medications on the lien were prescribed by licensed physicians in accordance with the standard of care for the plaintiff's injuries. Reducing these costs below the lien balance effectively tells physicians that their prescribing decisions were unreasonable — a finding the trial court should not make without competing medical evidence.

[!TIP] When responding to a remittitur motion, attach the MERIT report as an exhibit to the opposition brief. This allows the judge to review the clinical documentation without retrieving the trial exhibit — making it easier to deny the motion.

Protecting Against Appellate Reduction

On appeal, the key to protecting pharmacy damages is the sufficiency of the trial record:

Preserve all evidentiary objections. If the defense objected to pharmacy evidence at trial, ensure those objections were ruled on and the evidence was admitted. Evidence excluded at trial cannot support the verdict on appeal.

Brief the standard of review. Damages awards are reviewed for abuse of discretion. Emphasize the deference owed to the jury's finding, the clinical evidence supporting the pharmacy costs, and the defense's failure to present competing clinical evidence at trial.

Address each challenged medication. If the defense challenges specific medications on appeal, respond with the MERIT report's medication-specific analysis. Each medication was clinically necessary, prescribed by a treating physician, and related to accident injuries.

Comparative Fault Set-Offs

In comparative fault jurisdictions, the set-off is mathematical and applies to the entire verdict, including pharmacy costs. The pharmacy lien holder cannot avoid the comparative fault reduction.

Planning for set-offs. If comparative fault is likely, factor the potential reduction into the pharmacy lien recovery expectation. A 25% comparative fault finding reduces a $20,000 pharmacy damages award to $15,000 — below the lien balance if the lien exceeds $15,000.

Negotiating post-verdict reductions. When the comparative fault set-off reduces the pharmacy damages below the lien balance, LienScripts works with the attorney on post-verdict reduction negotiations. The reduction acknowledges the legal reality of comparative fault while protecting the maximum possible recovery.

Collateral Source Issues

Statutory framework varies. Some states allow collateral source set-offs for available health insurance coverage. If the plaintiff had insurance that could have covered some medications, the defense may argue for a reduction.

MERIT documentation addresses collateral source arguments. The MERIT report documents clinical reasons why health insurance was not used — formulary exclusions, prior authorization barriers, subrogation complexity — providing the evidentiary basis for opposing collateral source set-offs.

[!KEY] Post-verdict pharmacy lien protection is built during trial, not after. The MERIT report, pharmacist testimony, and physician correlation create the evidentiary record that withstands remittitur, appellate review, and set-off challenges.

How LienScripts Supports Post-Verdict Recovery

LienScripts provides MERIT documentation and dispensing records designed for trial use and post-verdict protection. The structured, pharmacist-signed MERIT report serves as both a trial exhibit and an appellate record, providing the clinical evidence needed to defend pharmacy damages through post-verdict motions and appeals. LienScripts also participates in post-verdict reduction negotiations when comparative fault or other factors reduce the available recovery.

Contact LienScripts to discuss trial and post-verdict strategies for pharmacy lien cases.

Related Resources

• Trial Preparation with Pharmacy Evidence
• Pharmacy Lien Bifurcation Strategy
• Expert Witness Pharmacy Testimony
• Settlement Allocation of Pharmacy Costs

Frequently Asked Questions

Can a post-verdict motion eliminate pharmacy costs from the damages award?

Yes. A successful motion for remittitur or JNOV can reduce or eliminate the pharmacy component of the damages award. Strong clinical documentation through the MERIT report and pharmacist testimony is the best defense against these motions.

How does comparative fault affect pharmacy lien recovery?

Comparative fault reduces the entire verdict proportionally, including the pharmacy damages component. A 25% fault finding reduces a $20,000 pharmacy award to $15,000. If the pharmacy lien exceeds the reduced amount, post-verdict reduction negotiations may be necessary.

What is the most important step for protecting pharmacy liens on appeal?

Building a strong trial record. The MERIT report must be admitted into evidence, pharmacist or expert testimony must explain the clinical rationale for each medication, and treating physicians should confirm the accident-related basis for prescriptions. This record gives the appellate court sufficient evidence to uphold the damages award.

Does LienScripts negotiate post-verdict pharmacy lien reductions?

Yes. When post-verdict motions, comparative fault, or appellate decisions reduce the available recovery below the pharmacy lien balance, LienScripts works with the attorney on reduction negotiations that acknowledge the legal outcome while protecting maximum pharmacy lien recovery.